9 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 2 / Phase 32026-10-09NCT06616584
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 32026-10-02NCT01436968
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFcardiovascular disorder, heart disorder, heart failureRecruitingPhase 32026-09-28NCT07761117
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderClostridoides Difficile Associated DiseaseRecruitingPhase 32026-09-09NCT07282665
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsCognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorderRecruitingPhase 42026-09-01NCT04262206
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPreviously Treated Non-Small Cell Lung CancerRecruitingPhase 2 / Phase 32026-05-18NCT03851445
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerAdnexal Diseases, Carcinoma, Ovarian Epithelial, Death, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, astrocytoma (excluding glioblastoma), benign urinary system neoplasm, bone marrow disorder, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cancer, carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, glioblastoma, glioma, gonadal disorder, hematologic disorder, intestinal disorder, kidney cancer, kidney disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, myelodysplastic syndrome, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, osteosarcoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, rectal disorder, rectal neoplasm, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm, small cell lung carcinoma, stomach disorder, urinary system disorderRecruitingNot applicable2026-04-30NCT05297734
Study of ALTO-300 in MDDdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22025-07-24NCT05922878
ALTO-100 in Bipolar Disorder With Depression (BD-D)Bipolar Disorder I or II With a Major Depressive EpisodeRecruitingPhase 22025-07-16NCT06656416